跳至主要内容
临床试验/ISRCTN35866380
ISRCTN35866380已完成不适用

Voriconazole study: treatment of chronic endobronchial Aspergillus infection with voriconazole in patients with cystic fibrosis

Erasmus Medical Centre (The Netherlands)0 个研究点目标入组 20 人开始时间: 2005年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Confirmed diagnosis of CF (documented by positive sweat test and/or by positive rectal current measurement, and/or genotype consistent with CF, two positive CF mutations, accompanied with two or more clinical features consistent with the CF phenotype)
  • 2. At least three positive cultures for Aspergillus in the two years prior to the study
  • 3. Positive galactomannan test at the start of the study
  • 4. Older than 2 years of age

排除标准

  • 1. Allergy to voriconazole
  • 2. Use of drugs contraindicating use of voriconazole:
  • 2.1. Terfanadine
  • 2.2. Astemizol
  • 2.3. Cisapride
  • 2.4. Pimozide
  • 2.5. Kinidine
  • 2.6. Rifampicide
  • 2.7. Carbamazepine
  • 2.8. Phenobarbital
  • 2.9. Ergotamine alkaloiden
  • 2.10. Sirolimus
  • 3. Use of liposomal amphotericine B
  • 4. Use of high dose prednisone
  • 5. Inability to produce sputum
  • 6. Poor compliance
  • 7. Pregnancy

研究者

发起方
Erasmus Medical Centre (The Netherlands)

相似试验